Technology · Synthetic biology investment

Synthetic biology investment in Germany in 2026

Investment in synthetic biology in Germany reached 120 M $ in 2026, ranking the country 19 out of 197. Funding is concentrated in Munich and Berlin, where startups like Theraptosis and T-knife develop synthetic gene circuits for cancer therapy. The German approach is pragmatic: investors favor projects with clear industrial applications, such as enzyme and bioplastic production.

Data for 2026 · unit: $
Position

Germany world ranking

#19 / 197

Country position on the scale from last to first place for this indicator.

DE
#19
#197#1
Trend

Change over time

Change in indicator over the available period.

10 M
2000
50 M
2010
100 M
2020
200 M
2025
120 M
2026

Values — $

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Synthetic biology investment in Germany — how much?
Based on 2026 data — 120 M $. This is rank #19 out of 197 countries.
What is Germany's rank by Synthetic biology investment?
Germany ranks #19 out of 197 countries in the world ranking by «Synthetic biology investment».
How has Synthetic biology investment changed in Germany?
Over the available period the indicator changed from 10 M to 120 M $.